Active	Status	Sponsor type	Region	Phase	Filter
14 Active 0 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

14 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nakamura, Yukio
NCT02156960: Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients	Recruiting	4	100	Japan	Denosumab treatment in osteoporotic patients, Teriparatide treatment in osteoporotic patients, Denosumab and teriparatide treatment in osteoporotic patients	Shinshu University	Osteoporosis	05/15	11/22
NCT02157012: Evaluation of the Condition of Rheumatoid Arthritis After Treatment	Recruiting	4	100	Japan	The effectiveness of Xeljanz in rheumatoid arthritis patients	Shinshu University, Showa Inan General Hospital	Rheumatoid Arthritis	04/22	03/25
NCT02156999: Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment	Recruiting	4	100	Japan	Ibandronic acid, vitamin D	Shinshu University	Osteoporosis	10/22	12/25
NCT03315676: Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers	Recruiting	2	124	Japan	Oral Bonoprazan, Oral Esomeprazol	Shinshu University	Gastrointestinal Erosions and/or Ulcers	11/22	09/25
NCT03183557: Efficacy of Zoledronic Acid in Osteoporosis	Recruiting	2	100	Japan	"Zoledronic acid", "Reclast®", "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"	Shinshu University	Osteoporosis	12/22	06/25
NCT03186131: Efficacy of Oral Ibandronate in Osteoporosis	Recruiting	2	100	Japan	Ibandronate, Oral Ibandronate and Vitamin D	Shinshu University	Osteoporosis	12/22	06/25
NCT03784261: Usefulness of Non TNF Usage in RA Patients	Recruiting	2	90	Japan	Drug: "Salirumab", Drug: "Tocilizmab", Drug: "Abatacept"	Shinshu University	Rheumatoid Arthritis	12/22	12/24
NCT03702140: Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy	Recruiting	2	90	Japan	"Teriparatide", "Forteo® or Teribon"	Shinshu University	Osteoporosis	10/23	10/25
NCT03755466: Examination of Efficacy and Safety of Baricitinib in RA Patients	Recruiting	2	90	Japan	"Baricitinib", "olumiant®", "Biologics", Tofacitinib 5 MG [Xeljanz]	Shinshu University	Rheumatoid Arthritis	11/23	11/25
NCT03755193: Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients	Recruiting	2	90	Japan	SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug", Bisphosphonates and ELD "Edirol®Tablet 0.75ug", ELD "Edirol®Tablet 0.75ug"	Shinshu University	Osteoporosis	11/24	11/26
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain	Active, not recruiting	2	314	Europe, Canada, Japan, US, RoW	GSK3858279, Placebo	GlaxoSmithKline	Pain, Osteoarthritis, Knee	08/24	12/24
NCT02306187: The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis	Recruiting	1	100	Japan	Edirol, Eldecalcitol	Shinshu University	Osteoporosis	12/22	12/24
NCT02327650: To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations	Recruiting	N/A	200	Japan	The examinations for bones in joints of OA and RA patients	Shinshu University	Progression of Rheumatoid Arthritis, Osteoarthritis of Multiple Joints	04/22	12/24
NCT02329093: Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA	Recruiting	N/A	100	Japan	To MRI-detecting bone signal changes in radiographic hip OA	Shinshu University	Hip OA	11/23	11/26